Complement activation and regulation in rheumatic disease
Open Access
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 45, 101339
Abstract
No abstract availableKeywords
Funding Information
- Leiden University Medical Center
- European Research Council (724517)
This publication has 129 references indexed in Scilit:
- The C-Type Lectin of the Aggrecan G3 Domain Activates ComplementPLOS ONE, 2013
- Anti-C1q Autoantibodies, Novel Tests, and Clinical ConsequencesFrontiers in Immunology, 2013
- Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatmentArthritis Research & Therapy, 2012
- The major risk alleles of age-related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA)Clinical and Experimental Immunology, 2011
- Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damageProceedings of the National Academy of Sciences, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activationMolecular Immunology, 2009
- Complement activation and inhibition: a delicate balanceTrends in Immunology, 2009
- The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisProceedings of the National Academy of Sciences, 2008
- Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)Clinical and Experimental Immunology, 2006